1-nitroacridine/tumor inhibitor compositions

Details 1-nitroacridine/tumor inhibitor compositions 1-nitroacridine/tumor inhibitor compositions

2001-02-16

2009-11-24

Canella, Karen A (Department: 1643)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S105000

Reexamination Certificate

active

07622478

ABSTRACT:
The invention is directed to 1-nitroacridine derivative(s)/tumor inhibitor(s) compositions as well as methods for using said compositions for inhibiting or preventing tumor growth, particularly, prostate cancer cell growth and metastases.

REFERENCES:
patent: 3694447 (1972-09-01), Pagano et al.
patent: 4139531 (1979-02-01), Ledóchowski et al.
patent: 4603125 (1986-07-01), Atwell et al.
patent: 4985436 (1991-01-01), Pettit et al.
patent: 4996237 (1991-02-01), Pettit et al.
patent: 5529989 (1996-06-01), Pettit et al.
patent: 5561122 (1996-10-01), Pettit et al.
patent: 5604237 (1997-02-01), Dumaitre et al.
patent: 5639725 (1997-06-01), O'Reilly et al.
patent: 5696131 (1997-12-01), Baguley et al.
patent: 5759514 (1998-06-01), Mattes et al.
patent: 5891864 (1999-04-01), Han et al.
patent: 6326390 (2001-12-01), Leung et al.
patent: 6538038 (2003-03-01), Pero et al.
patent: 038 572 (1980-10-01), None
patent: 038 572 (1981-10-01), None
patent: 05331070 (1993-02-01), None
patent: WO 99/16889 (1999-04-01), None
patent: WO99/34788 (1999-07-01), None
patent: 99/58126 (1999-11-01), None
Battegay (Journal of Molecular Medicine, 1995, vol. 73, pp. 333-346).
Wilson et al (Journal of Medicinal Chamistry, 1989, vol. 32, pp. 23-30).
Denny et al (Journal of Medicinal Chemistry, 1990, vol. 33, pp. 1288-1295).
Shalinsky et al (Ann NY Acad Sci, 1999, vol. 878, pp. 236-270).
Grosios et al (British Journal of Cancer, 1999, vol. 81, pp.1318-1327).
Colleoni et al (American Journal of Clinical Oncology: Cancer Clinical Trials, (Aug. 1997) vol. 20, No. 4, pp. 383-386.
Drug Facts and Comparisons (1999, Cada et al, Ed, p. 3283).
abstract of Tew et al (Pharmacology and Experimental Therapeutics, 1992, vol. 56, pp. 323-339).
Gately, 1997, Proc. Natl. Acad. Sic. USA 94:10868-10872.
Lee et al., 1996, J. Med. Chem, 39:2508-2517.
Mazerska et al., 1990, Arzneim.-Forsch./Drug Res. 40 (I), 4, 472-477.

Affiliated with

Also associated with

Rating

1-nitroacridine/tumor inhibitor compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 1-nitroacridine/tumor inhibitor compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-nitroacridine/tumor inhibitor compositions will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4080000